008 - "Follow the Opportunity" with Marta New episode artwork

EPISODE · Nov 24, 2021 · 55 MIN

008 - "Follow the Opportunity" with Marta New

from Let's Combinate - Drugs + Devices · host Subhi Saadeh

On this episode, I had Marta New PhD MBA. Marta and I talk about how business school changed her perspective, depth vs. the value of information when it comes to decision making, mentors in her career and their influence on her development, her experience starting a new company, her time in venture capital and the due diligence process, lessons during the pandemic and some of the influences that inspire her. Happy Thanksgiving! Marta is the CEO of Radyus Research. Before starting Radyus, Marta was the co-founding Partner at Agent Capital, a life sciences-focused venture capital firm based in Cambridge, MA. While at Agent, Marta participated in multiple deals in oncology, immunology and rare disease areas including Orchard Therapeutics (NASDAQ:ORTX), Precision Biosciences (NASDAQ:DITL), Pliant Therapeutics and Verge Genomics, among others. Prior to Agent Capital, Marta was a Principal investor at Baxalta Ventures, the corporate venture capital arm of Baxalta in Cambridge MA, where she was  on the investment dilligence team and served as a board observer for Gadeta BV (acquired by Kite/Gilead, 2018), Syntimmune (acq. by Alexion, 2018), and Vitesse Biologics (early stage accelerator funded by Baxalta, Mayo Clinic and Velocity Pharmaceutical Development). Marta started her investment career at Baxter Ventures, the corporate venture capital arm of Baxter in Chicago, IL, transitioning from the Global Renal Marketing franchise, where she was the commercial lead for multiple new products for the Chinese and European markets. She joined Baxter from Northwestern University’s Innovation and New Ventures Office where she was responsible for licensing negotiations, commercial assessment of patents, and industry alliance management. She received her Ph.D. from the University of Illinois at Chicago in microbiology and immunology and completed her post-doctoral training at Northwestern University. She also received an MBA from Northwestern University Kellogg School of Management in Chicago, IL.

On this episode, I had Marta New PhD MBA. Marta and I talk about how business school changed her perspective, depth vs. the value of information when it comes to decision making, mentors in her career and their influence on her development, her experience starting a new company, her time in venture capital and the due diligence process, lessons during the pandemic and some of the influences that inspire her. Happy Thanksgiving! Marta is the CEO of Radyus Research. Before starting Radyus, Marta was the co-founding Partner at Agent Capital, a life sciences-focused venture capital firm based in Cambridge, MA. While at Agent, Marta participated in multiple deals in oncology, immunology and rare disease areas including Orchard Therapeutics (NASDAQ:ORTX), Precision Biosciences (NASDAQ:DITL), Pliant Therapeutics and Verge Genomics, among others. Prior to Agent Capital, Marta was a Principal investor at Baxalta Ventures, the corporate venture capital arm of Baxalta in Cambridge MA, where she was  on the investment dilligence team and served as a board observer for Gadeta BV (acquired by Kite/Gilead, 2018), Syntimmune (acq. by Alexion, 2018), and Vitesse Biologics (early stage accelerator funded by Baxalta, Mayo Clinic and Velocity Pharmaceutical Development). Marta started her investment career at Baxter Ventures, the corporate venture capital arm of Baxter in Chicago, IL, transitioning from the Global Renal Marketing franchise, where she was the commercial lead for multiple new products for the Chinese and European markets. She joined Baxter from Northwestern University’s Innovation and New Ventures Office where she was responsible for licensing negotiations, commercial assessment of patents, and industry alliance management. She received her Ph.D. from the University of Illinois at Chicago in microbiology and immunology and completed her post-doctoral training at Northwestern University. She also received an MBA from Northwestern University Kellogg School of Management in Chicago, IL.

NOW PLAYING

008 - "Follow the Opportunity" with Marta New

0:00 55:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

The PFN Cincinnati Bengals Podcast Pro Football Network The PFN Cincinnati Bengals Podcast is where you can stay up-to-date with the latest news and analysis on the Cincinnati Bengals! Our hosts, industry experts Jay Morrison and Dallas Robinson, provide weekly coverage of all the latest rumors and updates about the Bengals. Don’t forget to follow the show to receive new episodes directly in your podcast feed and leave a rating and review to let us know your thoughts. TV 2 - Veien til EM TV 2 og Moderne Media Velkommen til TV 2's EM podkast. Dette er tidenes første EM-podkast fra TV 2. I dagene før kamper skal Jesper Mathisen, Jan-Henrik Børslid og Espen Solbakken m/gjester lade opp. God fornøyelse! For annonsering: [email protected] booking: [email protected] Generally American (A Journey in American English) Christopher M. Chandler, Kris Schauer Hello, Hola, Guten Tag, Bonjour, こんにちは !Welcome everyone, this is a podcast for those wanting to learn about U.S. culture through Standard American English, also known as General American. We talk about various different topics related to the U.S. and the U.S.'s relations with other countries. My co-host and I would like to think of this as more of a journey because you never know where it’ll take us. Plus, since the journey’s more important than the end or the start, we hope that you’ll be willing to join us! Let’s see where it takes us! What's Next In Mastercard Welcome to 'What's Next In,' the new Mastercard podcast that covers trends and topics that affect our lives professionally, personally and globally."What's Next In" informally explores big ideas and trends from different parts of the business and explains how Mastercard is leading the industry into the future. Hosted by Vicki Hyman, managing editor of the Mastercard Newsroom. She'll discuss with our resident thought-leaders, experts and employees how Mastercard is helping shape the future and set the standard by harnessing these emerging trends and leading conversations on these topics.Subscribe now and let Mastercard show you… What's Next In…

Frequently Asked Questions

How long is this episode of Let's Combinate - Drugs + Devices?

This episode is 55 minutes long.

When was this Let's Combinate - Drugs + Devices episode published?

This episode was published on November 24, 2021.

What is this episode about?

On this episode, I had Marta New PhD MBA. Marta and I talk about how business school changed her perspective, depth vs. the value of information when it comes to decision making, mentors in her career and their influence on her development, her...

Can I download this Let's Combinate - Drugs + Devices episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!